J. Hirsh

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Jeffrey I. Weitz, Monika Hudoba, David Massel et al. · Journal of Clinical Investigation · 1990 · 1.1K citations · Full text

Medicine, Cardiology, Pharmacology +16

Low molecular weight heparin

J. Hirsh, Levine Mn · Blood · 1992 · 903 citations · Full text

Life Sciences, Biochemistry, Hemostasis +3

Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis

R. Hull, J. Hirsh, Richard M. Jay et al. · New England Journal of Medicine · 1982 · 736 citations

Medicine, Hematology, Pharmacotherapy +17

Low molecular weight heparin

J. Hirsh, MN Levine · Blood · 1992 · 675 citations · Full text

Life Sciences, Biochemistry, Hemostasis +3

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

Mark N. Levine, J. Hirsh, Michael Gent et al. · The Lancet · 1994 · 513 citations

Pharmacy, Pharmacology, Pharmacotherapy +9